October 12, 2023 at 3:51 pmOzempic’s Ripple Effect Felt in Dialysis Market Novo Nordisk (NVO) has ended its study of Ozempic’s impact on kidney failure in diabetes patients almost a year ahead of schedule due to strong… [Read More]
